These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1166 related items for PubMed ID: 28753793

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.
    He T, Lu C, Gong W, Ge Z, Li R, Li X, Sun C, Li W, Long Q, Liu Q, Lai Y.
    Front Biosci (Landmark Ed); 2024 May 13; 29(5):186. PubMed ID: 38812297
    [Abstract] [Full Text] [Related]

  • 26. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L, Yang G, Zhao D, Wang J, Bai Y, Peng Q, Wang H, Fang R, Chen G, Wang Z, Wang K, Li G, Yang Y, Wang Z, Guo P, Peng L, Hou D, Xu W.
    Mol Cancer; 2019 Apr 11; 18(1):86. PubMed ID: 30975145
    [Abstract] [Full Text] [Related]

  • 27. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
    Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, Watanabe M, Baba H.
    Cancer; 2013 Mar 15; 119(6):1159-67. PubMed ID: 23224754
    [Abstract] [Full Text] [Related]

  • 28. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
    Chen X, Li R, Li X, Peng X, Zhang C, Liu K, Huang G, Lai Y.
    Pathol Res Pract; 2021 Nov 15; 227():153625. PubMed ID: 34628264
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
    Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E.
    Tumour Biol; 2015 Jun 15; 36(6):4643-53. PubMed ID: 25631748
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
    Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R, Slaby O.
    J Transl Med; 2012 Mar 22; 10():55. PubMed ID: 22440013
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Serum exosomal miR-210 as a potential biomarker for clear cell renal cell carcinoma.
    Wang X, Wang T, Chen C, Wu Z, Bai P, Li S, Chen B, Liu R, Zhang K, Li W, Chen Y, Xing J.
    J Cell Biochem; 2019 Feb 22; 120(2):1492-1502. PubMed ID: 30304555
    [Abstract] [Full Text] [Related]

  • 37. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M, Zhou Y, Xia T, Zhou X, Huang Z, Zhang H, Zhu W, Ding Q, Wang S.
    Breast Cancer Res Treat; 2018 Jul 22; 170(2):257-270. PubMed ID: 29557526
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
    Zhang ZY, Li YC, Geng CY, Zhou HX, Gao W, Chen WM.
    Hematol Oncol; 2019 Oct 22; 37(4):409-417. PubMed ID: 31102419
    [Abstract] [Full Text] [Related]

  • 40. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
    Qi Y, Wang L, Wang K, Peng Z, Ma Y, Zheng Z, Shang D, Xu W, Zheng J.
    Biomed Pharmacother; 2019 Mar 22; 111():821-834. PubMed ID: 30616081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.